Bone loss in survival motor neuron (Smn(-/-) SMN2) genetic mouse model of spinal muscular atrophy.
Spinal muscular atrophy (SMA) is characterized by degenerating lower motor neurons and an increased incidence of congenital bone fractures. Survival motor neuron (SMN) levels are significantly reduced due to deletions/mutations in the telomeric SMN1 gene in these patients. We utilized the Smn(-/-) SMN2 mouse model of SMA to determine the functional role for SMN in bone remodelling. microCT analysis of lumber vertebrae, tibia and femur bones from SMA mice revealed an osteoporotic bone phenotype. Histological analysis demonstrated a thin porous cortex of cortical bone and thin trabeculae at the proximal end of the growth plate in the vertebrae of SMA mice compared to wild-type mice. Histochemical staining of the vertebrae showed the presence of abundant activated osteoclasts on the sparse trabeculae and on the endosteal surface of the thin cortex in SMA mice. Histomorphometric analysis of vertebrae from SMA mice showed an increased number of osteoclasts. Serum TRAcP5b and urinary NTx levels were elevated, consistent with increased bone resorption in these mice. SMA mice showed a significant decrease in the levels of osteoblast differentiation markers, osteocalcin, osteopontin and osterix mRNA expression; however, there were no change in the levels of alkaline phosphatase expression compared to WT mice. SMA mouse bone marrow cultures revealed an increased rate of osteoclast formation (54%) and bone resorption capacity (46%) compared to WT mice. Pre-osteoclast cells from SMA mice showed constitutive up-regulation of RANK receptor signalling molecules critical for osteoclast differentiation. Our results implicate SMN function in bone remodelling and skeletal pathogenesis in SMA. Understanding basic mechanisms of SMN action in bone remodelling may uncover new therapeutic targets for preventing bone loss/fracture risk in SMA.
Shanmugarajan
Srinivasan
S
Charles P. Darby Children's Research Institute, Charleston, SC 29425, USA.
Tsuruga
Eichi
E
Swoboda
Kathryn J
KJ
Maria
Bernard L
BL
Ries
William L
WL
Reddy
Sakamuri V
SV
D000818:Animals; D015415:Biomarkers / Q000032:analysis; D015519:Bone Density; D016723:Bone Remodeling; D002478:Cells, Cultured; D015870:Gene Expression; D021621:Imaging, Three-Dimensional; D051379:Mice; D018345:Mice, Knockout; D023421:Models, Animal; D009134:Muscular Atrophy, Spinal / Q000235:genetics* / Q000473:pathology*; D010010:Osteoclasts / Q000378:metabolism / Q000473:pathology; D053246:Receptor Activator of Nuclear Factor-kappa B / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D015398:Signal Transduction / Q000502:physiology; D055540:Survival of Motor Neuron 2 Protein / Q000235:genetics*; D013977:Tibia / Q000000981:diagnostic imaging / Q000378:metabolism / Q000473:pathology*; D014057:Tomography, X-Ray Computed
D015415:Biomarkers; D053246:Receptor Activator of Nuclear Factor-kappa B; D055540:Survival of Motor Neuron 2 Protein; C505687:Tnfrsf11a protein, mouse